REVIEW

Testarea anticorpilor IgG specifici alimentelor la copiii cu suspiciune de alergie sau intoleranţă alimentară – analiza riscurilor nutriţionale și a implicaţiilor clinice

Food-specific IgG testing in children with suspected food allergy or intolerance – a review of nutritional risks and clinical implications

Data publicării: 21 Octombrie 2026
Data primire articol: 03 August 2026
Data acceptare articol: 04 August 2026
Editorial Group: MEDICHUB MEDIA
10.26416/JourNutri.11.3.2026.11802
Descarcă pdf

Abstract

Introduction. Adverse food reactions, such as food allergies or food intolerances, represent a growing global concern, affecting quality of life and nutritional health. In this context, commercial food-specific IgG tests are widely promoted despite lacking validation and being discouraged by major allergy societies.

Objective. In this review, we examine the biological basis of food-specific IgG antibodies and analyze current evidence regarding their diagnostic value, with particular attention to potential clinical and nutritional implications in pediatric populations.

Materials and method. A structured search was conducted in PubMed, ScienceDirect, Scopus and Web of Science (mainly for 2016-2026). Eligible publications included reviews, clinical studies, guidelines and position papers in English, French, Spanish and Romanian addressing food-specific IgG/IgG4, food allergy or intolerance and diet-based interventions. Pediatric data were prioritized, while adult studies were used when necessary to clarify mechanisms. Evidence was appraised qualitatively and synthesized thematically.

Results. Most studies indicate that food-specific IgG, particularly IgG4, reflects exposure and oral tolerance rather than pathological hypersensitivity. Available data do not show reliable discrimination between symptomatic and asymptomatic individuals, and FS‑IgG-guided diets are supported mainly by small, methodologically limited studies. In children, IgG-based elimination diets may induce nutrient deficiencies, impair growth, disturb the gut microbiome and delay accurate diagnosis of true food allergy or other conditions.

Conclusions. Current evidence does not support food-specific IgG testing for diagnosing food allergy or intolerance in children. Elevated titers usually indicate prior exposure, while IgG-guided dietary restrictions may entail substantial nutritional and clinical risks; diagnostic strategies should therefore rely on validated, guideline-endorsed methods.



Keywords
food-specific IgGpediatric food allergyfood intoleranceelimination dietnutritional risk

Rezumat

Introducere. Reacţiile adverse la alimente, precum alergiile sau intoleranţele alimentare, reprezintă o preocupare globală în creștere, afectând calitatea vieţii și starea de sănătate nutriţională. În acest context, testele comerciale pentru determinarea anticorpilor IgG specifici alimentelor sunt promovate la scară largă, în ciuda lipsei validării știinţifice și a faptului că sunt descurajate de principalele societăţi de alergologie.

Obiectiv. În această analiză examinăm baza biologică a anticorpilor IgG specifici alimentelor și dovezile actuale privind valoarea lor diagnostică, cu accent pe potenţialele implicaţii clinice și nutriţionale pentru populaţia pediatrică.

Materiale și metodă. A fost realizată o căutare structurată în bazele de date PubMed, ScienceDirect, Scopus și Web of Science (în principal pentru perioada 2016-2026). Publicaţiile eligibile au inclus articole de tip review, studii clinice, ghiduri și documente de poziţie publicate în limbile engleză, franceză, spaniolă și română, care au abordat anticorpii IgG/IgG4 specifici alimentelor, alergiile sau intoleranţele alimentare și intervenţiile dietetice. Au fost prioritizate datele pediatrice, iar studiile efectuate la adulţi au fost incluse pentru a clarifica mecanismele biologice. Dovezile au fost evaluate calitativ și sintetizate tematic.

Rezultate. Majoritatea studiilor indică faptul că anticorpii IgG specifici alimentelor, în special IgG4, reflectă expunerea la alimente și dezvoltarea toleranţei orale, mai degrabă decât existenţa unei hipersensibilităţi patologice. Datele disponibile nu demonstrează capacitatea de diferenţiere între persoanele simptomatice și cele asimptomatice, iar dietele bazate pe rezultatele testelor de IgG sunt susţinute în principal de studii de dimensiuni reduse, cu limitări metodologice importante. La copii, dietele de eliminare ghidate de testele IgG pot determina deficienţe nutriţionale, pot afecta creșterea și dezvoltarea, pot perturba microbiota intestinală și pot întârzia diagnosticul corect al unei alergii alimentare reale sau al altor afecţiuni.

Concluzii. Dovezile actuale nu susţin utilizarea testelor IgG specifice alimentelor pentru diagnosticul alergiilor sau intoleranţelor alimentare la copii. Titrurile crescute ale anticorpilor indică, de regulă, expunerea anterioară la aliment, în timp ce restricţiile alimentare bazate pe aceste rezultate pot implica riscuri clinice și nutriţionale semnificative. Prin urmare, strategiile diagnostice ar trebui să se bazeze pe metode validate și recomandate de ghidurile de specialitate.

Cuvinte Cheie
IgG specifice alimenteloralergii alimentareintoleranţe alimentaredietă de excludererisc nutriţional

1. Introduction

Adverse food reactions, such as food allergies or food intolerances, represent a growing global concern, affecting quality of life and nutritional health. From a theoretical perspective, food allergies are adverse immune responses to specific food proteins, usually IgE-mediated. IgE-mediated allergies typically present with manifestations such as anaphylaxis, urticaria, angioedema and/or acute gastrointestinal symptoms (e.g., vomiting, abdominal pain, diarrhea). Clinically non-IgE-mediated allergies, such as food protein-induced enterocolitis syndrome or food protein-induced allergic proctocolitis, involve different immunological pathways, and they are generally characterized by delayed-onset symptoms(1-3). At the same time, food intolerances are nonimmune mediated reactions and may arise from metabolic, toxicological, pharmacological or undefined mechanisms. The most common examples include lactose and fructose intolerance, non-celiac gluten sensitivity, as well as reactions to food additives, biogenic amines and fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs)(1-3).

Over the past decade, the prevalence of food allergies has increased, particularly in industrialized, high-income countries(4). While heightened awareness and improved diagnostic tools may explain part of this increase, evidence suggests that the true prevalence is also rising. Based on the existing reports, in 2023, food allergies affected up to 10% of children and adults worldwide, excluding non-IgE-mediated allergies such as food protein-induced enterocolitis syndrome (FPIES), while we must take into consideration that the data related to the above statement may be underreported(5,6). The rapid rise in food allergy prevalence likely reflects complex gene-environment interactions(7).

This growing prevalence of food allergies and intolerances has sparked interest in alternative diagnostic approaches, including food-specific IgG testing, despite its controversial clinical utility. Testing for food-specific IgG antibodies has become increasingly popular as a method to identify potentially problematic foods, particularly in individuals with negative or inconclusive allergy or intolerance test results. Yet, the scientific validity and, therefore, clinical utility remain contentious within the medical community(9,10).

In this narrative review, we examine the biological basis of food-specific IgG antibodies and analyze current evidence regarding their diagnostic value, with particular attention to potential clinical and nutritional implications in pediatric populations.

2. Materials and method

This work is a narrative review based on a structured literature search regarding food-specific IgG testing in the context of food allergy and intolerance, with a particular focus on pediatric populations. A formal systematic review protocol was not registered. However, predefined search strategies and eligibility criteria were applied in order to improve transparency and reduce arbitrary study selection. An extensive search was performed in academic databases such as PubMed, ScienceDirect, Scopus and Web of Science, using combinations of keywords including “food IgG” AND “food allergy”, OR “food intolerance”, “pediatric”, “clinical guidelines”, “elimination diet”, “nutritional risks” and “gold standard”.

The search focused primarily on papers published between 2016 and 2026, with earlier publications included only for theoretical background or to contextualize current guideline recommendations. We included publications in Romanian, French, Spanish and English, including narrative reviews, systematic reviews, meta-analyses, randomized controlled trials and observational studies directly relevant to the topic. Clinical guidelines and official positions from medical societies were also included. Studies in children and adolescents were prioritized, while adult data were considered when necessary to clarify mechanisms or diagnostic issues relevant to pediatric practice. Case reports, letters to the editor and conference abstracts without full text were excluded. Articles not addressing human food-specific IgG testing, allergy/intolerance diagnosis, or focusing on unrelated adverse food reactions were also excluded. When multiple reports overlapped, the most recent or methodologically robust publication was preferentially retained (Figure 1).

Figure 1. Flow diagram of the literature search and study selection process (adapted from PRISMA principles)
Figure 1. Flow diagram of the literature search and study selection process (adapted from PRISMA principles)

Titles and abstracts were screened for relevance, followed by full-text assessment of potentially eligible studies. Given the narrative design and heterogeneity of study designs, populations and outcomes, no formal quantitative synthesis or meta-analysis was performed. Instead, evidence was appraised qualitatively, considering study design, sample size, pediatric applicability and methodological clarity. The main findings were then organized thematically to integrate immunological mechanisms, diagnostic limitations, nutritional risks and current guideline positions (Figure 1).

3. Thematic findings and discussion

3.1. IgG and oral tolerance mechanisms

Food-specific IgG antibodies are a natural component of the adaptive immune response to continuous food antigen exposure, especially at intestinal mucosal surfaces(11). These antibodies are produced as an active immunologic mechanism, preventing inflammatory responses to normal dietary proteins. According to the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Nutrition (DGE) and the German Professional Association of Pediatricians (BVKJ), elevated food-specific IgG levels mainly indicate prior exposure and, in most cases, immunologic tolerance rather than a pathological reaction(12-14).

Oral tolerance involves complex, tightly regulated processes mediated by regulatory T cells, particularly induced Tregs that migrate to the intestinal lamina propria. There, they interact with dendritic cells, suppressing allergic Th2 responses while promoting IgG4 and IgA production, alongside increased IL-10 production(15,16). Consistently, higher food-specific IgG4 often associates with the induction and maintenance of immune tolerance. Experimental studies suggest that IgG signaling via its inhibitory receptor FcγRIIB can attenuate IgE-dependent mast cell and basophil activation, suggesting a protective role in food allergy. Moreover, during oral immunotherapy, antigen-specific IgG and IgA responses are commonly induced, potentially modulating effector-cell activation and suppression of IgE-mediated reactions(9,17,18).

IgG’s biological effects depend on interactions with Fcγ receptors. Binding to the inhibitory receptor FcγRIIB on mast cells or basophils inhibits inflammatory mediator release, whereas large antigen-IgG immune complexes can activate receptors like FcγRI or FcγRIII, potentially promoting tissue inflammation. This may explain the apparently dual role of IgG responses in different immunological contexts, acting as a marker of tolerance in healthy individuals while potentially contributing to inflammatory processes in specific pathological states like irritable bowel syndrome (IBS) or inflammatory bowel disease(19,20).

Distinguishing total IgG from IgG subclasses, particularly IgG4, is of fundamental importance for accurately interpreting immune response to food antigens, since different subclasses have distinct immunological roles, from allergen-blocking antibodies to potentially pathogenic effects. The role of IgG4 is remarkably nuanced. Importantly, food-specific IgG4 must be distinguished from IgG4-related disease (IgG4-RD): while IgG4-RD involves systemic fibro-inflammation, food-specific IgG4 represents a physiological marker of immune tolerance and successful desensitization(21,22). Within oral tolerance and allergen immunotherapy contexts, increased allergen-specific IgG4 is widely regarded as a marker of protective regulatory immune responses. It is commonly interpreted as reflecting functional inhibition of IgE-mediated effector pathways, including competition with IgE for allergen binding and signaling through inhibitory receptors such as FcγRIIB, as well as participation in immune complexes(4).

Failure to distinguish total IgG from IgG4 significantly limits clinical interpretation, as elevated total IgG may include antibodies with diverse or nonspecific roles and does not necessarily reflect tolerance or pathology. Without standardization and contextualized immunological interpretation, IgG test results can be overestimated and used inappropriately in pediatrics(10,17,18,23,24). Therefore, a positive IgG test result without relevant clinical symptoms may reflect a varied, healthy diet rather than indicating a food sensitivity(10,25).

This immunological balance is also influenced by the hygiene hypothesis, suggesting that reduced early-life microbial exposure impairs proper immune maturation. This often leads to gut microbiome dysbiosis, which can derail oral tolerance mechanisms. A diverse microbiome is vital for inducing Tregs and maintaining IL-10 levels. When dysbiosis occurs, the resulting increase in intestinal permeability can lead to an unfiltered “leakage” of antigens. This not only disrupts homeostasis but may also explain the elevated IgG titers seen in some individuals, as the immune system reacts to a higher systemic load of food proteins crossing a compromised barrier(1,13,26,27).

Oral tolerance in the gut is maintained by a coordinated cellular network. Dendritic cells in the intestinal lamina propria capture food antigens and facilitate the differentiation of native T-cells into regulatory T-cells. These Tregs secrete key immunosuppressive cytokines, most notably IL-10, which suppress proinflammatory Th2 responses and signal B-cells to switch production to IgG4. In this scenario, IgG4 acts as a blocking antibody, competing with IgE for antigen binding and effectively preventing mast cell degranulation(15,18,21,28,29).

3.2. IgG level dynamics and clinical correlation

Clinically, reductions in IgG levels following elimination diets are expected and physiologically explainable. Because IgG titers reflect exposure to specific food antigens, eliminating that food from the diet naturally leads to decreased specific IgG antibody production. Studies have shown decreased food-specific IgG4 in children after elimination diets, sometimes associated with symptom improvement, as seen in irritable bowel syndrome(30). Such a reduction primarily reflects antigen exposure, rather than clinical improvement, or confirmation of any IgG-diagnosable pathology. These decreases do not consistently correlate with symptom improvement or allergy/intolerance diagnosis; rather, they may reflect reduced antigen exposure, placebo effects, or non-specific symptom relief(10). A study conducted on a pediatric sample of 407 subjects, of whom 67 followed an exclusion diet based on positive FS-IgG4 test results, concluded that adherence to the diet led to a reduction in specific food allergy symptoms. Although the findings are innovative, the study has several limitations in establishing causality. These include probiotic supplementation in 36 subjects (53.73%) for a period of three months concomitantly with the diet, as well as the study’s retrospective observational design(31).

Food-specific IgG test results lack validation by recognized standard medical evaluations for allergy or intolerance diagnosis. For example, a study published in 2018 and conducted on 80 obese adults with gastrointestinal symptoms found no significant associations between self-perceived milk and wheat intolerance and corresponding s-IgG and/or s-IgA antibodies(23). To date, relatively few studies have specifically evaluated these associations in pediatric populations.

While a handful of recent studies have suggested potential clinical benefits, these findings must be viewed through a critical lens. For instance, research has pointed toward symptom improvement in irritable bowel syndrome using IgG-guided exclusion diets, and others have explored correlations between food-specific IgG and functional constipation or Body Mass Index (BMI) in underweight populations. However, the methodological rigor of these studies often falls short of the gold standard required for clinical validation(30,32-35).

Finally, while environmental factors are dominant, omics studies suggest that gene-environment interactions play a quiet but crucial role. Single nucleotide polymorphisms in genes regulating Fcγ receptors or cytokine production (such as IL-10) can modulate how intensely an individual’s immune system responds to food antigens. Although these genetic variations do not yet have direct diagnostic utility, they help explain the high variability of IgG titers among healthy people on similar diets. This further reinforces the idea that an elevated IgG level is often an individual biological trait rather than a marker of disease(29,36).

3.3. Current research status and testing limitations

Food-specific IgG testing research is extensive, yet most evidence converges on a lack of clinical utility. Overall, the available literature reveals substantial methodological limitations. A clear molecular distinction between IgE-mediated versus non-IgE-mediated responses is essential. The IgG response represents primarily exposure and tolerance markers rather than direct pathogenicity. However, ambivalent IgG roles in allergies are being investigated, with some IgG antibodies possibly contributing to inflammation through immune complex formation(9,37). Although IgG subclasses in oral tolerance are recognized, precise molecular mechanisms by which perturbing this balance might translate into clinical symptoms outside IgE-mediated allergies are not elucidated(16).

Most studies supporting IgG testing are observational or cross-sectional and carry a high risk of bias, making it difficult to establish a causal relationship between IgG presence and symptoms. More robust data would require randomized, double-blind, placebo-controlled trials correlating IgG changes with oral food challenge results, molecular inflammation markers, and intestinal barrier integrity(38,39). In addition, IgG testing methods vary significantly between laboratories, and the lack of assay standardization and uniform result interpretation further contributes to inconsistent findings(10).

Misinterpretation can lead to unnecessary elimination diets, posing significant risks, particularly in pediatric populations. In children, whose periods of rapid growth impose specific nutritional requirements, unjustified dietary restrictions may result in macro- and micronutrient deficiencies, with negative consequences for both physical and cognitive development. Restrictive diets may also alter the gut microbiome, with potential long-term immunological consequences, including disruption of the delicate balance underlying immune tolerance(1,10,23).

Consistent with the literature and clinical guidelines, laboratory test result interpretation must always remain subordinated to clinical context and overall child nutritional assessment, since validated diagnostic methods (oral food challenge, skin tests and specific IgE quantification) remain essential for grounding clinical decisions. The use of tests without demonstrated diagnostic value, such as food-specific IgG testing, risks diverting attention from validated diagnostic pathways and leading to unnecessary dietary restrictions that compromise growth, development and a healthy relationship with food. Several reports in the literature suggest that unjustified elimination diets may lead to severe nutritional deficiencies, negative impacts on physical and cognitive development, and disruption of the delicate immune tolerance balance(9,10,24,35,39-42).

Despite lacking scientific validation and negative medical recommendations, food-specific IgG tests are frequently used, often at patients’ requests or on recommendation from non-evidence-based healthcare providers. Commercial availability and aggressive marketing maintain the popularity of these tests, despite their controversy. Most analyses reach consumers directly by private laboratories or online platforms, often without medical involvement or adequate clinical interpretation. Marketing strategies frequently employ terminology like hidden intolerance, chronic inflammation or delayed allergies, concepts neither recognized nor scientifically validated within allergy diagnostics. This approach amplifies parental anxiety and drives restrictive diet implementation without a medical/nutritional foundation. In pediatric populations, this becomes particularly relevant, potentially leading to actual nutritional problems, increasing malnutrition risk and disrupting immune homeostasis(9,10,24).

3.4. Gold standard and complementary diagnostic methods

According to the European Academy of Allergy and Clinical Immunology (EAACI), the double-blind, placebo-controlled oral food challenge (OFC) remains the gold standard for food allergy diagnosis. This test involves ingesting suspected foods and placebos under double-blind conditions, eliminating both patient and clinician bias while carefully observing the symptoms. Abrams and Becker (2017) performed a study on 313 children with food allergies and concluded that there is a high risk (33%) of challenge failure and anaphylaxis to peanut, tree nut and, in particular, cashew. Though costly, time-consuming and carrying an allergic reaction risk, this method confirms causal relationships(43-45).

For allergy diagnosis, other complementary methods include detailed clinical history, skin prick tests (SPT) and allergen-specific IgE quantification. Recently, component-resolved diagnostics and basophil activation tests (BAT) offer improved specificity, evaluating responses to individual allergenic components or direct effector cell activation. For food intolerances, the diagnosis depends on specific mechanisms, like hydrogen breath tests for lactose or fructose intolerance, or carefully monitored elimination-reintroduction diets(1,46).

3.5. Potential pediatric risks of long-term elimination diets guided by IgG test results

In pediatric populations, the clinical implications of IgG-guided elimination diets extend beyond diagnostic accuracy and directly affect nutritional status and growth. Although the controversy surrounding IgG testing and the lack of clinical validation apply equally to both pediatric and adult populations, the risks of unjustified elimination diets are considerably greater in children because of their age-specific nutritional vulnerability, critical periods of growth and development, and variable nutrient requirements. A 2018 review published by a Polish research team highlighted the importance of continuous dietitian supervision when restrictive elimination diets are prescribed in pediatric patients, as oral nutritional supplementation is often necessary to ensure adequate development(47).

Inappropriate dietary exclusions carry substantial and well-documented risks. Severe dietary restrictions during periods of rapid growth may lead to deficiencies in essential macronutrients and micronutrients, with negative effects on physical growth and cognitive development(10,47). In 2025, a retrospective study conducted on a sample of 1237 children and published by Zeng et al. (2025) investigated the association between food-specific IgG and BMI and reported promising data for wheat and soy. However, because of major methodological limitations, the authors themselves concluded that the clinical utility of IgG testing remained limited and insufficient at that time(32). Because children have higher nutrient requirements relative to body weight and depend on diverse diets for adequate growth and neurodevelopment, unnecessary food exclusions may disproportionately increase the risk of micronutrient deficiencies.

Restrictive diets can alter gut microbiome composition and diversity, disrupting beneficial-pathogenic bacterial balance with potential long-term implications for digestive and immune health. A study from the USA published in 2022 suggested that transient intestinal barrier immaturity may amplify IgG-mediated absorption disturbances, further underscoring the need for a cautious diagnostic approach(26,27,32). In addition, prolonged food avoidance or later introduction, especially of common foods, may impair oral tolerance and potentially increase the risk of IgE-mediated allergy upon reintroduction(4,48). Furthermore, reliance on IgG test results may lead some parents to delay appropriate medical evaluation, thereby postponing the correct diagnosis of underlying conditions and the implementation of effective treatment strategies (Figure 2).

Figure 2. Conceptual framework illustrating the potential consequences of food-specific IgG testing
Figure 2. Conceptual framework illustrating the potential consequences of food-specific IgG testing

3.6. Clinical recommendations and current guideline positions

Clinical guidelines and official positions from major international medical societies, such as the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of Allergy, Asthma and Immunology (AAAAI) and the Canadian Society of Allergy and Clinical Immunology (CSACI), strongly discourage using food-specific IgG/IgG4 testing for food allergy or intolerance diagnosis. These organizations emphasize that IgG antibody presence carries no diagnostic clinical relevance, and they should not be the basis of a dietary recommendation. Consensus holds that these tests should be used exclusively for research purposes(14,19,43,49,50).

3.7. Future research directions

Future research should focus on combining IgG analysis with metagenomics, metabolomics and proteomics studies, which could offer more data regarding complex diet – gut microbiome – immune system interactions and identify novel markers and therapeutic targets(32,36). Monitoring IgG dynamics during dietary interventions and rigorously correlating results with relevant clinical and immunological markers to clearly distinguish causality from correlation. Investigating IgG subclass roles and their interactions with Fcγ receptors across various immune cells is essential, considering that, while IgG4 associates with tolerance, other subclasses like IgG1 or IgG3 might harbor different or ambivalent roles(25,51). Also, advanced animal models and in vitro systems to decode molecular and cellular signaling of IgG responses to food antigens are needed to include these tests in clinical use(13).

3.8. Limitations

This review presents certain limitations inherent to its narrative design. Although structured search strategies were employed and international guidelines and consensuses prioritized, our study selection did not follow systematic protocols, introducing potential selection and interpretation biases specific to narrative reviews. Nevertheless, the narrative approach allowed the integration of immunological, clinical and nutritional perspectives that are difficult to synthesize using strictly quantitative methods. This comprehensive approach allowed us to present strong arguments against the clinical use of IgG testing and underscored the need for robust medical education and strict adherence to evidence-based guidelines.

A major limitation of this review is the very limited number of pediatric studies addressing food-specific IgG testing, which required partial extrapolation of mechanistic and clinical data from adult populations when interpreting potential implications for children. Precisely because of this scarcity of pediatric evidence, the present synthesis is particularly relevant, as it highlights that the use of food-specific IgG testing in children may be associated with substantial nutritional and clinical risks, despite its persistent commercial promotion.

These findings highlight the importance of adequate patient education regarding the physiological meaning of IgG responses and the potential risks of unnecessary elimination diets. Interdisciplinary collaboration among allergists, immunologists, gastroenterologists and nutritionists/dietitians remains important for ensuring evidence-based management and preventing damaging consequences from unvalidated diagnostic and therapeutic approaches.

4. Conclusions

In light of the current evidence, we conclude that food-specific IgG antibody testing is not a clinically validated method for food sensitivity diagnosis, and it remains unendorsed by international medical guidelines. Positive results most often indicate physiological exposure and immunological tolerance to foods rather than pathological reactions. Implementing exclusion diets based on these tests, particularly among children, can carry severe nutritional consequences, disrupt the gut microbiome and delay the correct diagnosis. Future research should focus on elucidating the molecular complexity of oral tolerance and developing validated diagnostic markers while avoiding promoting tests with uncertain clinical utility. Until then, we highlight that gold standards and evidence-based diagnostic approaches must remain foundational pillars of clinical management in food allergy and intolerance.

 

 

Conflict of interests: none declared.

Financial support: none declared.

This work is permanently accessible online free of charge and published under the CC-BY.

Bibliografie


  1. Gargano D, Appanna R, Santonicola A, et al. Food Allergy and Intolerance: A Narrative Review on Nutritional Concerns. Nutrients. 2021;13(5):1638.
  2. Warren CM, Sehgal S, Sicherer SH, Gupta RS. Epidemiology and the Growing Epidemic of Food Allergy in Children and Adults Across the Globe. Curr Allergy Asthma Rep. 2024;24(3):95-106.
  3. Muthukumar J, Selvasekaran P, Lokanadham M, Chidambaram R. Food and food products associated with food allergy and food intolerance – An overview. Food Res Int. 2020;138:109780.
  4. Lee ECK, Trogen B, Brady K, Ford LS, Wang J. The Natural History and Risk Factors for the Development of Food Allergies in Children and Adults. Curr Allergy Asthma Rep. 2024;24(3):121-131.
  5. Gupta R, Marvel J, Tassinari P, et al. Global prevalence of pediatric and adult IgE-mediated food allergies: results: from the ASSESS FA study. Ann Allergy Asthma Immunol. 2023;131(5):S7-S8.
  6. Alska E, Doligalska A, Napiórkowska-Baran K, et al. Global Burden of Allergies: Mechanisms of Development, Challenges in Diagnosis, and Treatment. Life (Basel). 2025;15(6):878.
  7. Editorial. Food allergy is everyone’s business. Nat Food. 2021;2(5):301-302.
  8. Benedé S, Blázquez AB, Chiang D, Tordesillas L, Berin MC. The rise of food allergy: Environmental factors and emerging treatments. EBioMedicine. 2016;7:27-34.
  9. Gocki J, Bartuzi Z. Role of immunoglobulin G antibodies in diagnosis of food allergy. Postepy Dermatol Alergol. 2016;33(4):253-256.
  10. Chabane H, Doyen V, Bienvenu F, et al. Les dosages d’IgG anti-aliments: méthodes et pertinence clinique des résultats. Position du groupe de travail de biologie de la Société française d’allergologie. Rev Fr Allergol. 2018;58(4):334-357.
  11. Knol EF, van Neerven RJJ. IgE versus IgG and IgA: Differential roles of allergen-specific antibodies in sensitization, tolerization, and treatment of allergies. Immunol Rev. 2024;328(1):314-333.
  12. Cerovic V, Pabst O, Mowat AM. The renaissance of oral tolerance: merging tradition and new insights. Nat Rev Immunol. 2025;25(1):42-56.
  13. Sricharunrat T, Pumirat P, Leaungwutiwong P. Oral tolerance:Recent advances on mechanisms and potential applications. Asian Pac J Allergy Immunol. 2018;36(4):207-216.
  14. Worm M, Reese I, Ballmer-Weber B, et al. Guidelines on the management of IgE-mediated food allergies. Allergo J Int. 2015;24(7):256-293.
  15. Wambre E, Jeong D. Oral Tolerance Development and Maintenance. Immunol Allergy Clin North Am. 2018;38(1):27-37.
  16. Tordesillas L, Berin MC. Mechanisms of Oral Tolerance. Clin Rev Allergy Immunol. 2018;55(2):107-117.
  17. Kanagaratham C, El Ansari YS, Lewis OL, Oettgen HC. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy. Front Immunol. 2020;11:603050.
  18. Furiness KN, El Ansari YS, Oettgen HC, Kanagaratham C. Allergen-specific IgA and IgG antibodies as inhibitors of mast cell function in food allergy. Front Allergy. 2024;5:1389669.
  19. Garmendia JV, Sanctis JBD, García AH. Food-Specific IgG Antibodies: Decoding Their Dual Role in Immune Tolerance and Food Intolerance. Immuno. 2025;5(3):25.
  20. Uzunismail Y. May the activation of mast cells by IgG- food antigen complexes be the missing piece of irritable bowel syndrome puzzle?. Gastroenterol Hepatol Open Access. 2020;11(1):47-50.
  21. Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. Eur J Intern Med. 2016;27:1-9.
  22. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterization of a new disease. BMC Med. 2006;4(1):23.
  23. Qin L, Tang LF, Cheng L, Wang HY. The clinical significance of allergen-specific IgG4 in allergic diseases. Front Immunol. 2022;13:1032909.
  24. Lee TH, Wu YY, Chan JK, et al. Immunoglobulin G testing in the diagnosis of food allergy and intolerance. Hong Kong Med J. 2017;23(4):419-420.
  25. Wu M, Wang X, Sun L, Chen Z. Effects of Food-Specific IgG on Health Outcomes of Asymptomatic Physical Examination Population. Research Square. Preprint posted online October 12, 2021.
  26. Purdel C, Margină D, Adam-Dima I, Ungurianu A. The Beneficial Effects of Dietary Interventions on Gut Microbiota – An Up-to-Date Critical Review and Future Perspectives. Nutrients. 2023;15(23):5005.
  27. Vita AA, Zwickey H, Bradley R. Associations between food-specific IgG antibodies and intestinal permeability biomarkers. Front Nutr. 2022; 9:962093.
  28. Kubota S, Sugiura S, Takahashi M, et al. Kestose Increases the Relative Abundance of Faecalibacterium spp. and Nominally Increases Cow Milk Tolerant Dose in Children with Cow’s Milk Allergy – Preliminary Results. Pol J Microbiol. 2023;72(3):299-306.
  29. Liu J, Yin W, Westerberg LS, et al. Immune Dysregulation in IgG4-Related Disease. Front Immunol. 2021;12:738540.
  30. Cappelletti M, Tognon E, Vona L, et al. Food-specific serum IgG and symptom reduction with a personalized, unrestricted-calorie diet of six weeks in Irritable Bowel Syndrome (IBS). Nutr Metab. 2020;17(1):101.
  31. Yang B, Yu H, Yao W, et al. Food-specific IgG4-guided diet elimination improves allergy symptoms in children. Front Immunol. 2024;15:1281741.
  32. Zeng YC, Li CY, Song XL, et al. Food-specific IgG antibodies and body mass index: multivariate analysis of clinical correlations in underweight populations. Front Immunol. 2025;16:1650705.
  33. Sissoko NDN, Chen W, Wang C, et al. Associations between functional constipation and non-IgE-mediated food allergy in infants and children. Allergol Immunopathol (Madr). 2023;51(3):163-173.
  34. Ostrowska L, Wasiluk D, Lieners CFJ, Gałęcka M, Bartnicka A, Tveiten D. IgG Food Antibody Guided Elimination-Rotation Diet was more Effective Than FODMAP Diet and Control Diet in the Treatment of Women with Mixed IBS – Results from an Open Label Study. Research Square. Preprint posted online January 25, 2021.
  35. Lin S, Yang X, Xing Y, Wang X, Li Y. The Clinical Application Value of Multiple Combination Food Intolerance Testing. Iran J Public Health. 2019;48(6):1068-1073.
  36. Sindher SB, Chin AR, Aghaeepour N, et al. Advances and potential of omics studies for understanding the development of food allergy. Front Allergy. 2023;4.
  37. Dramburg S, Matricardi PM. Molecular Diagnosis of Allergy: The Pediatric Perspective. Front Pediatr. 2019;7:369.
  38. Kelso JM. Unproven Diagnostic Tests for Adverse Reactions to Foods. J Allergy Clin Immunol Pract. 2018;6(2):362-365.
  39. Carr S, Chan E, Lavine E, Moote W. CSACI Position statement on the testing of food-specific IgG. Allergy Asthma Clin Immunol. 2012;8(1):12.
  40. Wright K, Feeney M, Yerlett N, et al. Nutritional Management of Children with Food Allergies. Curr Treat Options Allergy. 2022;9:375-393.
  41. Mehta H, Groetch M, Wang J. Growth and nutritional concerns in children with food allergy. Curr Opin Allergy Clin Immunol. 2013;13(3):275-279.
  42. Cai S, Jiang L, Lu J, Ning L, Lu Q. Analysis of food-specific IgE, IgG, and IgG4 antibodies in children with allergic diseases. Am J Transl Res. 2026;18(1):605-617.
  43. Santos AF, Riggioni C, Agache I, et al. EAACI guidelines on the diagnosis of IgE-mediated food allergy. Allergy. 2023;78(12):3057-3076.
  44. Randhawa IS, Groshenkov K, Sigalov G. Food anaphylaxis diagnostic marker compilation in machine learning design and validation. PLoS One. 2023;18(4):e0283141.
  45. Abrams EM, Becker AB. Oral food challenge outcomes in a pediatric tertiary care center. Allergy Asthma Clin Immunol. 2017;13(1):43.
  46. Namazova-Baranova L, Efendieva K, Levina J, Kalugina V. Food Allergy and Food Intolerance – New Developments. Glob Pediatr. 2024;9:100201.
  47. Rekowska M, Czerwionka-Szaflarska M. Elimination diets – necessity or individual choice?. Pediatr Pol. 2019;93(6):472-478.
  48. Corica D, Aversa T, Caminiti L, Lombardo F, Wasniewska M, Pajno GB. Nutrition and Avoidance Diets in Children with Food Allergy. Front Pediatr. 2020;8:518.
  49. Soares-Weiser K, Takwoingi Y, Panesar SS, et al. The diagnosis of food allergy: a systematic review and meta-analysis. Allergy. 2014;69(1):76-86.
  50. Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-1025.
  51. Shi L li, Xiong P, Yang M, et al. Role of IgG4 Antibodies in Human Health and Disease. Cells. 2025;14(9):639.
Articole din ediția curentă

ORIGINAL ARTICLE

Influenţa modelelor sociale asupra obiceiurilor nutriţionale din școală

Bogdan Filimon, Monica Tarcea
Alimentaţia sănătoasă în perioada adolescenţei reprezintă un factor important pentru creșterea și dezvoltarea fizică și cognitivă, dar și pentru menţinerea stării de sănătate. Mediul școlar și cadrele didactice pot contribui semnificativ la formarea comportamentelor alimentare ale elevilor, atât......
REVIEW

Inducerea diabetului gestaţional în studiile experimentale pe animale

Adriana Pană, Attila Brassai
Diabetul gestaţional (DG) este cea mai frecventă tulburare metabolică în sarcină, asociindu-se cu riscuri semnificative, atât pentru mamă, cât și pentru făt. Obiectivul studiului a fost identificarea diferitelor modele experimentale de DG și a metodelor de inducere asociate, utilizate în studiile......
NARRATIVE REVIEW

Malnutriţia la pacientul critic – evaluarea riscului, strategii de prevenţie și monitorizare

Mircea Stoian, Ștefan Manea, Adina Stoian
Malnutriţia și riscul nutriţional sunt frecvente la pacientul critic și se asociază cu pierderea accelerată a masei musculare, cu slăbiciunea dobândită în terapie intensivă, prelungirea ventilaţiei mecanice și cu rezulta...
Articole din edițiile anterioare

REVIEW

Inducerea diabetului gestaţional în studiile experimentale pe animale

Adriana Pană, Attila Brassai
Diabetul gestaţional (DG) este cea mai frecventă tulburare metabolică în sarcină, asociindu-se cu riscuri semnificative, atât pentru mamă, cât și pentru făt. Obiectivul studiului a fost identificarea diferitelor modele experimentale de DG și a metodelor de inducere asociate, utilizate în studiile......
NARRATIVE REVIEW

Optimizarea managementului nutrițional în neuroblastomul pediatric: revizuire narativă a strategiilor și intervențiilor disponibile

Roxana-Maria Martin-Hadmaș, Tamara Cheșcheș, Ștefan-Adrian Martin
Neuroblastomul reprezintă una dintre cele mai agresive neoplazii solide ale copilăriei, statusul nutrițional având un impact major asupra toleranței la tratamentul oncologic, evoluției clinice și a ca...